Poland
· Delayed Price · Currency is PLN Medinice Statistics
Total Valuation
Medinice has a market cap or net worth of PLN 51.83 million. The enterprise value is 49.63 million.
| Market Cap | 51.83M |
| Enterprise Value | 49.63M |
Important Dates
The last earnings date was Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Medinice has 6.46 million shares outstanding. The number of shares has increased by 1.79% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 6.46M |
| Shares Change (YoY) | +1.79% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.31% |
| Owned by Institutions (%) | 13.94% |
| Float | 3.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 237.75 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 8.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.31 |
| EV / Sales | 227.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.49 |
| Quick Ratio | 2.35 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -83.93 |
Financial Efficiency
Return on equity (ROE) is -13.52% and return on invested capital (ROIC) is -9.35%.
| Return on Equity (ROE) | -13.52% |
| Return on Assets (ROA) | -8.26% |
| Return on Capital (ROIC) | -9.35% |
| Revenue Per Employee | 13,625 |
| Profits Per Employee | -274,188 |
| Employee Count | 16 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.36% in the last 52 weeks. The beta is 1.06, so Medinice's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -15.36% |
| 50-Day Moving Average | 9.13 |
| 200-Day Moving Average | 9.39 |
| Relative Strength Index (RSI) | 34.25 |
| Average Volume (20 Days) | 17,250 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medinice had revenue of PLN 218,000 and -4.39 million in losses. Loss per share was -0.68.
| Revenue | 218,000 |
| Gross Profit | 118,000 |
| Operating Income | -4.95M |
| Pretax Income | -4.39M |
| Net Income | -4.39M |
| EBITDA | -4.83M |
| EBIT | -4.95M |
| Loss Per Share | -0.68 |
Balance Sheet
The company has 2.86 million in cash and 660,000 in debt, giving a net cash position of 2.20 million or 0.34 per share.
| Cash & Cash Equivalents | 2.86M |
| Total Debt | 660,000 |
| Net Cash | 2.20M |
| Net Cash Per Share | 0.34 |
| Equity (Book Value) | 30.59M |
| Book Value Per Share | 4.73 |
| Working Capital | 3.70M |
Cash Flow
| Operating Cash Flow | -3.11M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 54.13% |
| Operating Margin | -2,271.56% |
| Pretax Margin | -2,012.39% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Medinice does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.79% |
| Shareholder Yield | -1.79% |
| Earnings Yield | -8.46% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medinice has an Altman Z-Score of 6.7.
| Altman Z-Score | 6.7 |
| Piotroski F-Score | n/a |